CorMedix Inc

Short Term Long Term Short Term Comparison Long Term Comparison

CRMD
1d-7.88%
1w13.26%
1m41.21%
1y2.09%
CRMD
1y2.09%
5y-37.00%
10y207.43%
20y0.00%

Bitcoin
-0.82%
-9.09%
-6.40%
106.24%
Bitcoin
106.24%
1,146.32%
11,770.30%
0.00%

Ethereum
-0.90%
-11.75%
-14.49%
45.57%
Ethereum
45.57%
1,828.08%
0.00%
0.00%

Gold
0.26%
2.56%
11.41%
20.52%
Gold
20.52%
88.92%
85.82%
499.35%

Silver
0.47%
4.25%
15.38%
14.30%
Silver
14.30%
94.94%
48.08%
306.93%

Apple
-2.19%
1.78%
0.04%
5.09%
Apple
5.09%
260.11%
-66.73%
39,041.00%

Amazon
-1.68%
-1.44%
4.92%
78.52%
Amazon
78.52%
96.45%
-43.46%
7,943.96%

Microsoft
-1.96%
-2.97%
-0.67%
45.75%
Microsoft
45.75%
259.81%
923.86%
2,532.12%

S&P 500
-1.20%
-2.84%
-1.08%
22.34%
S&P 500
22.34%
74.12%
171.80%
346.13%

Dow & Jones
-0.65%
-2.95%
-2.53%
11.36%
Dow & Jones
11.36%
42.65%
129.74%
261.03%

ATH

ATH Price$49.35
ATH Date2015-04-01
% since ATH-89.10%
% to ATH817.29%

ATL

ATL Price$0.83
ATL Date2012-08-17
% from ATL551.73%
Last Low Price$0.8705
Last Low Date2018-05-22
% From Last Low518.04%

IPO

IPO Price$3.20
% Current ROI USD168.13%
ATH Price$49.35
% ROI ATH 597,819.50%

[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="CRMD"]

Key Data [addtoany]

Current price	$5.38
Sector	Healthcare
Industry	Biotechnology
Today's High/Low	$6.17/$5.155
Volume	1,497,937.00
Previous Close	$5.84
52 Week High/Low	$7/$2.57
Market Cap	321,089,632.00
P/E Ratio	0
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$-0.09
Annualized Dividend	$0

$5.38

[addtoany]

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally.
It primarily focuses on the development of its lead product candidate DefenCath/Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology.
The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31
Cash on hand	$28.33	$17.62	$11.98	$20.17	$35.39	-	-	-	-	-	-	-
Receivables	$0003500	$0.01	$0.06	$0.01	$0.32	$0.08	-	-	-	-	-	-
Inventory	$0.34	$0.43	$0.59	$0.17	$0.38	$0.46	$0.08	$0	$0	-	-	-
Pre-Paid Expenses	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	$0.50	$0.43	$0	$0	$0.60	$0.16	$0.24	$0.30	$0.05	$0.53	$0.18	$0500000
Total Current Assets	$29.35	$18.67	$13.27	$21.83	$37.06	$5.04	$0	$0	$2.53	-	-	-
Property, Plant, And Equipment	$0.13	$0.16	$0.19	$0.07	$0.04	$0.04	$0.04	$0500000	$0.01	$0.02	$0.02	$0.03
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	$0	$0	$0	$0	$0	$0	$0	-	-	-
Other Long-Term Assets	-	-	$0	$0500000	$0500000	$0.02	$0.02	$0.01	$0.01	$0.01	$0.52	$0.20
Total Long-Term Assets	$0.13	$0.16	$0.19	$0.07	-	-	-	-	-	-	-	-
Total Assets	$29.48	$18.83	$13.45	$21.91	$37.10	$5.10	$2.97	$1.15	$2.56	$8.85	$2.23	$1.62
Total Current Liabilities	$5.83	$7.77	$6.26	$4.09	$3.06	$1.43	$1.67	$1.48	$1.31	$1.58	$16.94	$13.65
Long Term Debt	-	$6.13	$0	$0	$0	$0	$0	$0	$0	-	-	-
Other Non-Current Liabilities	-	-	-	-	$0.03	$0.04	$5.32	$0.01	$0.01	$0.02	-	-
Total Long Term Liabilities	$0267800	$6.13	$0	$0	-	-	-	-	-	-	-	-
Total Liabilities	$5.83	$13.89	$6.26	$4.09	$3.09	$1.46	$6.99	$1.49	$1.32	$1.59	$16.94	$13.65
Common Stock Net	$0.03	$0.02	$0.07	$0.04	$0.04	$0.02	$0.02	$0.01	$0.01	$0.01	$0100000	$0200000
Retained Earnings (Accumulated Deficit)	$-195.42	$-178.99	$-152.17	$-119.16	$-94.39	$-76.20	$0	$0	$0	-	-	-
Comprehensive Income	-	-	$0	$0	$0	$0	$0	$0	$0	-	-	-
Other Share Holders Equity	$0.10	$0.10	$0.10	$0.08	$0.06	$0.10	-	-	-	-	-	-
Share Holder Equity	$23.65	$4.93	$7.19	$17.81	$34.01	$3.63	$0	$0	$1.24	$7.26	-	-
Total Liabilities And Share Holders Equity	$29.48	$18.83	$13.45	$21.91	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31
Revenue	$0.28	$0.43	$0.33	$0.22	$0.21	$0.19	$0200000	$0	$0	-	-	-
Cost Of Goods Sold	$0.37	$0.40	$0.11	$0.37	$0.32	$0.45	$0.20	$0	$0	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Expenses	$11.05	$18.82	$24.49	$15.74	$6.28	$1.32	$1.23	$1.14	$4.10	$5.49	$4.89	$3.08
SG&A Expenses	$9.87	$8.07	$8.65	$8.88	$10.26	$7.33	$3.49	$1.86	$3.15	$8.49	$6.05	$4.81
Other Operating Income Or Expenses	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	$21.29	$27.29	$33.25	$24.99	$16.86	$9.09	$4.72	$3	$7.25	-	-	-
Operating Income	$-21787600	$-26.86	$-32.92	$-24.76	$-16.65	$-8.90	$-4.92	$-3	$-7.25	-	-	-
Total Non-Operating Income/Expense	$0.30	$0.03	$0.01	$0.01	$-0.02	$-9	$-1.83	$0196500	$0.04	-	-	-
Pre-Tax Income	$-21.49	$-26.83	$-33991400	$-24.64	$-18.19	$-17.90	$-9.13	$-3.38	$-7.21	-	-	-
Income Taxes	$-5.06	$0	$0	$0	$0	$0	$0	$0	$-0.49	-	-	-
Income After Taxes	$-5.06	$0	$0	$0	$0	$0	$0	$0	$-0.49	-	-	-
Other Income	-	-	-	-	-	-	-	-	-	-	-	-
Income From Continuous Operations	$-16.43	$-26.83	$-33991400	$-24.64	$-18.19	$-17.90	$-9.13	$-3.38	$-6.71	-	-	-
Income From Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	$-16.43	$-26.83	$-33991400	$-24.64	$-18.19	$-20.45	$-9.13	$-3.38	$-6.71	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	$-21787600	$-26.86	$-32.92	$-24.76	$-16.65	$-8.90	$-4.92	$-3	$-7.25	-	-	-
Basic Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	$24	$108.88	$71.41	$40.43	$6	$4	$3	$2	$2	$2	$2	-
Basic EPS	-	-	-	-	-	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31
Net Income/Loss	$-16.43	$-26.83	$-33991400	$-24.64	$-18.19	$-20.45	$-9.13	$-3.38	$-6.71	-	-	-
Total Depreciation And Amortization - Cash Flow	$0.07	$0.07	$0.04	$0.03	$0.02	$0.02	$1.34	$0.36	$0.01	-	-	-
Change In Accounts Receivable	$0.01	$0.05	$-0.05	$0.31	$-0.25	$-0.09	$0	$0	$0	-	-	-
Change In Inventories	$0.06	$0.17	$-0.10	$0.08	$-0.04	$-0.56	$-0.08	$0	$0	-	-	-
Cash Flow From Operating Activities	$-15.05	$-23.70	$-28.59	$-22.27	$-12.53	$-6.32	$-3.62	$-2.28	$-6.30	-	-	-
Cash Flow From Investing Activities	$-12.02	$1.56	$10.36	$11.42	$-23.61	$-0.03	$-0.04	$0	$-0162500	-	-	-
Debt Issuance/Retirement Net - Total	$-0.23	$7.50	$7.50	$7.50	$7.50	$-0236600	$0.53	$1.27	-	-	-	-
Total Common And Preferred Stock Dividends Paid	-	-	$0	$0	$0	$0	$0	$0	$0	-	-	-
Financial Activities - Other	$1.77	$-0.11	$-0.11	$-0.11	$0.03	$1.32	$3.61	-	-	-	-	-
Cash Flow From Financial Activities	$25.80	$29.40	$20.52	$7.09	$43.63	$8.36	$5.20	$1.13	$23.86	$10.46	$2.27	$2.96
Net Cash Flow	$-1.27	$7.24	$2.32	$-3.75	$7.48	$1.97	$1.55	$-1.15	$-6.30	-	-	-
Common Stock Dividends Paid	-	-	$0	$0	$0	$0	$0	$0	$0	-	-	-